BACKGROUND: The presence and severity of coronary artery calcified plaque (CAC) differs markedly between individuals of African and European descent, suggesting that admixture mapping may be informative for identifying genetic variants associated with subclinical cardiovascular disease. METHODS AND RESULTS: Admixture mapping of CAC was performed in 1040 unrelated African Americans with type 2 diabetes mellitus from the African American-Diabetes Heart Study, Multi-Ethnic Study of Atherosclerosis and Family Heart Study using the Illumina custom ancestry informative marker panel. All cohorts obtained computed tomography scanning of the coronary arteries using identical protocols. For each ancestry informative marker, the probability of inheriting 0, 1, and 2 copies of a European-derived allele was determined. Linkage analysis was performed by testing for association between each ancestry informative marker using these probabilities and CAC, accounting for global ancestry, age, sex, and study. Markers on 1p32.3 in the GLIS1 gene (rs6663966, logarithm of odds [LOD]=3.7), 1q32.1 near CHIT1 (rs7530895, LOD=3.1), 4q21.2 near PRKG2 (rs1212373, LOD=3.0), and 11q25 in the OPCML gene (rs6590705, LOD=3.4) had statistically significant LOD scores, whereas markers on 8q22.2 (rs6994682, LOD=2.7), 9p21.2 (rs439314, LOD=2.7), and 13p32.1 (rs7492028, LOD=2.8) manifested suggestive evidence of linkage. These regions were uniformly characterized by higher levels of European ancestry associating with higher levels or odds of CAC. Findings were replicated in 1350 African Americans without diabetes mellitus and 2497 diabetic European Americans from Multi-Ethnic Study of Atherosclerosis and the Diabetes Heart Study. CONCLUSIONS: Fine mapping these regions will likely identify novel genetic variants that contribute to CAC and clarify racial differences in susceptibility to subclinical cardiovascular disease.
BACKGROUND: The presence and severity of coronary artery calcified plaque (CAC) differs markedly between individuals of African and European descent, suggesting that admixture mapping may be informative for identifying genetic variants associated with subclinical cardiovascular disease. METHODS AND RESULTS: Admixture mapping of CAC was performed in 1040 unrelated African Americans with type 2 diabetes mellitus from the African American-Diabetes Heart Study, Multi-Ethnic Study of Atherosclerosis and Family Heart Study using the Illumina custom ancestry informative marker panel. All cohorts obtained computed tomography scanning of the coronary arteries using identical protocols. For each ancestry informative marker, the probability of inheriting 0, 1, and 2 copies of a European-derived allele was determined. Linkage analysis was performed by testing for association between each ancestry informative marker using these probabilities and CAC, accounting for global ancestry, age, sex, and study. Markers on 1p32.3 in the GLIS1 gene (rs6663966, logarithm of odds [LOD]=3.7), 1q32.1 near CHIT1 (rs7530895, LOD=3.1), 4q21.2 near PRKG2 (rs1212373, LOD=3.0), and 11q25 in the OPCML gene (rs6590705, LOD=3.4) had statistically significant LOD scores, whereas markers on 8q22.2 (rs6994682, LOD=2.7), 9p21.2 (rs439314, LOD=2.7), and 13p32.1 (rs7492028, LOD=2.8) manifested suggestive evidence of linkage. These regions were uniformly characterized by higher levels of European ancestry associating with higher levels or odds of CAC. Findings were replicated in 1350 African Americans without diabetes mellitus and 2497 diabetic European Americans from Multi-Ethnic Study of Atherosclerosis and the Diabetes Heart Study. CONCLUSIONS: Fine mapping these regions will likely identify novel genetic variants that contribute to CAC and clarify racial differences in susceptibility to subclinical cardiovascular disease.
Authors: Paul N Hopkins; R Curtis Ellison; Michael A Province; James S Pankow; J Jeffrey Carr; Donna K Arnett; Cora E Lewis; Gerardo Heiss; Steven C Hunt Journal: Am J Cardiol Date: 2006-04-17 Impact factor: 2.778
Authors: Philip Greenland; Robert O Bonow; Bruce H Brundage; Matthew J Budoff; Mark J Eisenberg; Scott M Grundy; Michael S Lauer; Wendy S Post; Paolo Raggi; Rita F Redberg; George P Rodgers; Leslee J Shaw; Allen J Taylor; William S Weintraub; Robert A Harrington; Jonathan Abrams; Jeffrey L Anderson; Eric R Bates; Cindy L Grines; Mark A Hlatky; Robert C Lichtenberg; Jonathan R Lindner; Gerald M Pohost; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Robert A Vogel; Deborah J Wesley Journal: Circulation Date: 2007-01-12 Impact factor: 29.690
Authors: David Reich; Nick Patterson; Philip L De Jager; Gavin J McDonald; Alicja Waliszewska; Arti Tandon; Robin R Lincoln; Cari DeLoa; Scott A Fruhan; Philippe Cabre; Odile Bera; Gilbert Semana; M Ann Kelly; David A Francis; Kristin Ardlie; Omar Khan; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg; David A Hafler Journal: Nat Genet Date: 2005-09-25 Impact factor: 38.330
Authors: Pamela A Marcovitz; Hillary H Tran; Barry A Franklin; William W O'Neill; Michael Yerkey; Judith Boura; Michael Kleerekoper; Christine Z Dickinson Journal: Am J Cardiol Date: 2005-08-22 Impact factor: 2.778
Authors: Diane E Bild; Robert Detrano; Do Peterson; Alan Guerci; Kiang Liu; Eyal Shahar; Pamela Ouyang; Sharon Jackson; Mohammed F Saad Journal: Circulation Date: 2005-03-15 Impact factor: 29.690
Authors: B I Freedman; F C Hsu; C D Langefeld; S S Rich; D M Herrington; J J Carr; J Xu; D W Bowden; L E Wagenknecht Journal: Diabetologia Date: 2005-11-01 Impact factor: 10.122
Authors: László B Tankó; Claus Christiansen; David A Cox; Mary Jane Geiger; Michelle A McNabb; Steven R Cummings Journal: J Bone Miner Res Date: 2005-07-18 Impact factor: 6.741
Authors: Richard A Kronmal; Robyn L McClelland; Robert Detrano; Steven Shea; João A Lima; Mary Cushman; Diane E Bild; Gregory L Burke Journal: Circulation Date: 2007-05-14 Impact factor: 29.690
Authors: David T Redden; Jasmin Divers; Laura Kelly Vaughan; Hemant K Tiwari; T Mark Beasley; José R Fernández; Robert P Kimberly; Rui Feng; Miguel A Padilla; Nianjun Liu; Michael B Miller; David B Allison Journal: PLoS Genet Date: 2006-07-18 Impact factor: 5.917
Authors: Mingxia Yuan; Fang-Chi Hsu; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Mary E Comeau; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Carl D Langefeld; Barry I Freedman Journal: Obesity (Silver Spring) Date: 2016-06-29 Impact factor: 5.002
Authors: Lijun Ma; Carl D Langefeld; Mary E Comeau; Jason A Bonomo; Michael V Rocco; John M Burkart; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Donald W Bowden; Janice P Lea; Jenna O Krisher; Margo J Clay; Barry I Freedman Journal: Kidney Int Date: 2016-05-06 Impact factor: 10.612
Authors: Samson Y Gebreab; Pia Riestra; Rumana J Khan; Ruihua Xu; Solomon K Musani; Fasil Tekola-Ayele; Adolfo Correa; James G Wilson; Charles N Rotimi; Sharon K Davis Journal: Arterioscler Thromb Vasc Biol Date: 2015-03-05 Impact factor: 8.311
Authors: Barry I Freedman; Jasmin Divers; Gregory B Russell; Nicholette D Palmer; Donald W Bowden; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; Susan Carrie Smith; Carl D Langefeld; Keith A Hruska; Thomas C Register Journal: Am J Nephrol Date: 2015-12-23 Impact factor: 3.754
Authors: Jason A Bonomo; Nicholette D Palmer; John Cijiang He; Ying Fan; Pamela J Hicks; Janice P Lea; Mark D Okusa; Donald W Bowden; Barry I Freedman Journal: Am J Nephrol Date: 2015-10-24 Impact factor: 3.754
Authors: Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson Journal: J Am Soc Nephrol Date: 2014-08-04 Impact factor: 10.121